Health - Sep 29
As early as 2018, a research team of the MedUni Vienna showed that strict avoidance of all types of fish is in fact only necessary for few fish-allergy sufferers. However, reliable tests to determine which types could be tolerated and eaten have not been available until now. In their current study, the researchers demonstrate that a new and effective diagnostic procedure. The results of the study were published in the renowned "Journal of Allergy and Clinical Immunology: In Practice".
Physics - Sep 28

Researchers at TU Vienna and FHI Berlin succeeded in monitoring a catalytic reaction with three different microscopies under exactly the same conditions in real time. In this way, information is obtained that none of the methods alone could reveal.

Health - Sep 27

Although SARS-CoV-2 infections mainly attack the lungs, in many cases they can also damage other organs, such as the colon: around 60% of patients experienced digestive tract impacts. Researchers at MedUni Vienna have analysed the manifestations of Covid-19 in the lungs and colon and pinpointed the differences at a molecular level. Their findings, recently published in the "International Journal of Molecular Sciences", form the basis for the identification of novel biomarkers and the development of new treatment strategies.

Health - Sep 28

Hitherto, scientists have not fully understood why ticks are such dangerous disease vectors. A research team led by Johanna Strobl and Georg Stary from MedUni Vienna's Department of Dermatology shows that tick saliva inhibits the skin's defence function, thereby increasing the risk of diseases such as tick-borne encephalitis (TBE) or Lyme disease. The study was recently published in the Journal of Clinical Investigation.

Health - Sep 23

Anaplastic large cell lymphoma (ALCL) is an aggressive blood cancer that mainly affects children and adolescents, but it can also affect adults. A recent international study led by scientists from the Medical University Vienna and the Veterinary Medicine Vienna has now identified a new biomarker and effective therapeutic approach with the protein PDGFRβ and its downstream signaling pathway STAT3/5. According to the researchers, the inhibition of this axis promises a therapy with significantly improved prospects of success.

Selected Job Offers
Environment - 23.09
Wiss. Mitarbeiter*in (d/m/w) Technische Universität Berlin
Life Sciences - 08.09
Wissenschaftliche*r Mitarbeiter*in im Bereich Forschung und Entwicklung 3D Tissue Engineering mit Möglichkeit... Max-Planck-Institut für medizinische Forschung, Heidelberg
Economics/Business - 05.09
Wissenschaftlicher Assistent / Doktorand Universität Liechtenstein
Electroengineering - 02.09
Field Service Engineer (m/f/d) Scienta Omicron GmbH, 65232 Taunusstein
Employers of the Week